STRATEGIC-MANAGEMENT-PAPER - Lung Center Philippines
STRATEGIC-MANAGEMENT-PAPER - Lung Center Philippines
STRATEGIC-MANAGEMENT-PAPER - Lung Center Philippines
on
Submitted to:
Submitted by:
Eileen G. Aniceto, MD
Arianne B. Felipe
Karina D. Gapayao
Krizia Grace C. Ringpis
The Lung Center of the Philippines (LCP) is a leading tertiary hospital in the
Philippines that specializes in the diagnosis and treatment of lung and chest diseases.
Our mission is to provide high quality health services and state-of-the-art facilities for
the prevention, diagnosis and treatment of lung and chest diseases. In the recent years,
the LCP has taken on additional roles: 1. As the National Specialty Center for lung
and chest diseases enabling a network of regional lung centers and 2. As a COVID-19
referral center for moderate to severe disease.
The latter affected our center’s performance in an unprecedented manner as was the
rest of the world. Getting back on track after the pandemic was and continue to be a
challenge. This will require careful planning and strategic decision-making, including
the development of new programs and services, the optimization of existing resources,
and the cultivation of partnerships with other healthcare providers and stakeholders.
We do have a big window of opportunity with the growing demand for specialized
healthcare services and the increasing prevalence of respiratory diseases in the
Philippines. The LCP has the potential of expanding its operations and improving its
service delivery to meet the needs of its patients, at the same time, the LCP leverages
its expertise and reputation to strengthen its position as a leader in respiratory
healthcare in the Philippines and the surrounding countries in South East Asia.
Key external and internal factors were identified in the recent SWOT and PESTLE
analysis and the analysis matrix derived thereof showed that the LCP has maintained
a strong position in the market with remarkable competitive advantage. Our strengths
included our skilled workforce, complete array of diagnostic tools, state of the art
facilities, availability of advanced and specialized procedures, strong funding for the
Malasakit Fund which assured equitable access to our services. We have identified
certain weaknesses such as over dependence on subsidies, underutilization of our
services and outdated hospital information systems. There were opportunities
identified which we can use to our advantage like the increasing demand for
respiratory health services and our designation as a national specialty center. Threats
came in the form of rivalry from competing entrants and a worsening economy.
References …………………………………………………………………… 47
Appendices
The Lung Center of the Philippines (LCP) is a leading tertiary hospital in the
Philippines that specializes in the diagnosis and treatment of lung and chest diseases.
Ever since it was established in 1981 through Presidential Decree 1823, the LCP has
been at the forefront of respiratory healthcare in the country. 1 Our mission is to
provide high quality health services and state of the art facilities for the diagnosis and
management of lung and chest diseases, and promotion of lung health to every
Filipino, regardless of creed, sex, socioeconomic status or political affiliations. We
envision our institution to be at par with our southeast Asian counterparts and
eventually be globally competitive.
In addition, the Department of Health has designated the LCP to be the National
Specialty Center for lung and chest diseases in its efforts to align all stakeholders in a
single development plan in preparation for the implementation of the Universal
Health Care Act.2 In this framework, tertiary specialty hospitalized serve as apex
center, with a network of regional specialty centers. In our case, as the apex center
for lung and chest diseases, we are uniquely positioned to be able to expand our reach
nationwide enabling a network of regional lung centers.
The LCP has embarked on the Performance Governance System (PGS) strategic
framework in 2018, which gave the institution the strategic direction for the next 5-10
years. To be a regionally competitive, locally responsive premier institution for the
prevention, diagnosis and treatment of lung and chest diseases, providing quality
health care through excellent service, training and research. In the next five years, we
have developed a strategic road map that will put us at par with our south east asia
counterparts in providing advanced modalities in diagnosis and treatment of lung
disease. We have 5 core processes to develop strategically: under patient care –
provide quality specialized care for lung and chest diseases, including COVID; under
training – enhance competencies of personnel for specialized services and COVID
response; under research – lead researches that will impact on national health policies
and guidelines, especially for COVID; under advocacy – develop programs that
promote healthy lungs and environment and lastly, forge linkages among other
regional hospitals for transfer of skills and knowledge on lung and chest disease and
COVID. 3
The COVID-19 pandemic was paradox of sorts, on one hand putting on hold the
progress we have been making so far and on the other hand, being designated as a
COVID-19 referral center LCP was inundated with donations of medical equipment
and state of the art facilities that left us better equipped than ever. Not to mention the
particular skills and knowledge our pulmonary experts acquired from providing
service to thousands of COVID-19 patients and producing COVID-19 related research.
As a subject for strategic management, the LCP presents a unique set of challenges
and opportunities as we move on beyond the pandemic. Getting back on track will
require careful planning and strategic decision-making, including the development of
new programs and services, the optimization of existing resources, and the cultivation
of partnerships with other healthcare providers and stakeholders. We do have a big
window of opportunity with the growing demand for specialized healthcare services
Overall, the Lung Center of the Philippines presents an exciting and dynamic subject
for strategic management, offering the potential for growth, innovation, and
leadership in the field of respiratory healthcare.
A. Macro. To help the Lung Center of the Philippines (LCP) establish the
external factors that could impact decisions made by the Center, we used the PESTLE
(Political, Economic, Sociocultural, Technological, Legal, Environmental) Analysis
format. This analysis provides the top management team with contextual information
about the Center like the direction in which the business is heading, brand positioning,
growth targets, and help identifies the areas of concern that may lead to a decline in
growth and productivity.
b. Appointment of the new Department of Health (DOH) Secretary. The new DOH
secretary may have a unique vision for healthcare delivery, public health initiatives,
and strategies to address healthcare challenges. He can also prioritize certain public
health issues based on his expertise, background, and personal interests that can result
in a shift in resource allocation and the implementation of targeted interventions to
address priority health concerns. Also, with the newly appointed secretary, top
management leadership as well as their decisions can also be affected.
c.Tensions in the West Philippine Sea. If the tension in the West Philippine Sea
continues, the government may divert or reduce funds available for healthcare
institutions for its infrastructure, equipment, services and allocate instead to defense
and military purposes. It could also affect the timely delivery of healthcare resources
such as pharmaceuticals, medical equipment, etc. which may result in shortages and
increase in costs of products/services.
2. Economic Factors. The Lung Center of the Philippines (LCP) operates within the
context of the broader Philippine economy. As such, the general economic conditions
and forecasts for the country are important factors to consider when analyzing the
LCP's external environment.
b. Inflation Rate. Inflation rate is a big threat to the Center because we will also need
to adjust or increase our allocated budget due to increased operational costs including
personnel salaries, supplies and utilities. It may also result to an increase in the cost
of healthcare services including the medical consultations, hospitalization,
medications, diagnostic tests and medical procedures for our clients. Fortunately for
the Philippines, inflation rate has eased from 7.6% in March 2023, to 6.1% as of May
2023. 5. Be that as it may, the LCP should adjust the costing of diagnostic tests and
medical services in a timely manner in case of another surge in inflation rate.
5. Legal Factors. The LCP operates under the jurisdiction of the Department of
Health and the implementation of new laws and government policies will greatly
a. RA No. 11223 (Universal Healthcare Law) Universal Health Care (UHC) in the
Philippines aims to ensure that all Filipino people, regardless of their economic
circumstances, have access to high-quality healthcare services that can facilitate early
disease identification and management and so automatically enhance health outcomes.
10
Lung Center of the Philippines as a designated National Specialty Center for lung
and chest diseases, is in a strategic position to provide the majority of patients
equitable access to respiratory health care. The Health Care Network referral system
needs to be put in place for improved access.
c. Proposed CDC Bill. 12. This bill seeks to establish a Philippine Center for Disease
Control and Prevention (CDC). This Center will be the principal health protection
agency of the Philippines tasked to prevent, protect and manage the spread of diseases
and other health threats originating domestically and internationally. Also under this
bill, the CDC shall be the country’s epidemiology and surveillance body which is
sufficiently funded and equipped with bio-safety level 2-4 laboratories. It will be an
advantage to the LCP having a local CDC as a partner in the fight against Emerging
and Re-emerging Infectious Disease and will have to collaborate some functions so
that there will be alignment of our respective functions.
6. Environmental Factors
LCP regularly conducts a schedule of water maintenance and makes sure that all staff
are informed beforehand to not affect the operations and services relating to water
supply.
Porter's Five Forces analysis can be used to assess the competitive environment of the
Lung Center of the Philippines. Here's an analysis of each force:
1. Threat of new entrants: The threat of new entrants to the Lung Center of the
Philippines is low. While there may be respiratory healthcare services available in
other tertiary hospitals, LCP is the only Specialty Center for Lung and Chest diseases,
the only Government Owned and Controlled Corporation at that. There are significant
barriers to entry of private institutions with similar offerings, such as high start-up
costs and the need for specialized knowledge and expertise. However, as previously
discussed, setting up of a government owned and ran National Cancer Center within
the LCP grounds may constitute competition for our lung cancer diagnosis and
treatment program
2. Bargaining power of suppliers: The bargaining power of suppliers for the Lung
Center of the Philippines is relatively low. The government requires hospitals like the
LCP to go through the bidding process in procurement, where suppliers compete with
each other to offer the lowest price with the best quality of products and services.
Additionally, the Lung Center of the Philippines has the option to switch suppliers if
necessary, to ensure we are getting the best deal possible without compromising the
quality of care.
4. Threat of substitutes: The threat of substitutes for the Lung Center of the
Philippines is moderate. Patients may choose to seek healthcare services from other
healthcare providers offering similar respiratory care services. However, the Lung
Center of the Philippines can differentiate itself by being a government owned and
controlled corporation, with funding from government agencies to ensure equitable,
advanced, and high-quality respiratory care services.
Overall, the threat of new entrants and the bargaining power of suppliers are low. The
bargaining power of buyers and the threat of substitutes are moderate to high. The
intensity of competitive rivalry is high. The Lung Center of the Philippines can
differentiate itself by providing specialized respiratory care services and by offering
quality and affordable services to its patients. Additionally, the center can explore
ways to collaborate with other healthcare providers and expand its services to reach a
wider patient base.
Here are some potential threats and opportunities in the external environment analysis
for the Lung Center of the Philippines as identified in the annual SWOT and PESTLE
analysis.
Threats:
1. Political stability. Tensions in the West Philippine Sea can escalate into a war
which will adversely affect the economy in general and LCP operations in particular.
Not knowing who the future leaders of the DOH and our center will be in the next few
years will have some impact.
2. Economic conditions: Rising inflation rate can affect the demand for healthcare
services, including respiratory care services offered by the Lung Center of the
Opportunities:
To create an External Factor Evaluation (EFE) matrix for the Lung Center of the
Philippines, we identified and evaluated the most significant external factors affecting
the organization and identified each to either be a threat or an opportunity.
Based on the external factors analysis conducted using the EFE matrix, the Lung
Center of the Philippines has several strategic issues that need to be addressed to
improve its overall performance and competitiveness. Key strategic issues include
2. Competitive Rivalry: Proposals from several quarters to utilize LCP grounds for
projects like the National Cancer Center or CDC building will definitely be
duplication of services as well as competition for our lung cancer programs and
services. LCP should develop contingency plans to maintain competitive advantage
despite presence of these projects on lung center grounds
To give you an idea of the population of patients seen in our institution, here is the
census of cases seen in LCP from 2018 to 2022 according to the incidence rate.
Outpatient.
Pulmonary Tuberculosis has consistently topped the list of patients seen at the OPD
since 2018, followed by bronchiectasis, malignancies and chronic obstructive
pulmonary diseases.
For hospital admissions, malignancies are the number one cause for admission
followed by tuberculosis until the pandemic in 2020, when COVID-19 became the
predominant cause for admission.
2. State-of-the-art facilities: As laid out in the 5-10 year development plan, the Lung
Center of the Philippines has and is constantly acquiring state of the art facilities
equipped with the latest medical technologies and equipment to provide patients with
the best possible care. Here is the list of equipment that the LCP currently have:
1. 2D Echo Machine
2. Anesthesia Machine
3. Automatic Endoscopic Reprocessor
4. BiPap Machine
5. Bronchoscopy Thermal Vapor Ablation
6. Cardiac Monitor
7. Cell Counter Machine
8. Cell Saver
9. CPET (Ergometer)
10. CT Simulator
11. Defibrillator
12. ECG Machine
13. ECMO Machine
14. Endoscope Reprocessor
15. High Flow Nasal Cannula Machine
3. Research and development: The Lung Center of the Philippines has always had a
strong research and development, with 10-15 researches conducted by training
fellows. As part of our 5 year development plan, we envisioned a stronger department,
participating in more multi-center trials, developing more protocols for our new
programs and services, getting our researches published in peer reviewed journals
which will allow us to stay at the forefront of new treatments and therapies for
respiratory health care.
4. Reputation and brand recognition: The Lung Center of the Philippines has built a
strong reputation for providing high-quality respiratory care services over the years,
which has resulted in high brand recognition and patient loyalty. Especially during the
pandemic, the LCP has gained the reputation of providing the best health care for
moderate to severe COVID-19 with good clinical outcomes. Our tagline: LabanLung.
Overall, the Lung Center of the Philippines has many strengths in terms of its
resources and capabilities, which enable it to provide high-quality respiratory care
services to its patients. However, there may be some areas for improvement, such as
increasing utilization of new equipment and services, investing in new training
programs for staff or expanding its research and development efforts to further
improve its services.
1. Quality of care: The Lung Center of the Philippines has a strong reputation for
providing high-quality respiratory care services, which is a significant competitive
advantage. In the past few years, we have added new and advanced programs and
services to improve care for our patients. Whether providing basic or advanced
2. Technology and equipment: The Lung Center of the Philippines has programmed
the acquisition of state-of-the-art facilities and equipment in the next five years to
support its respiratory care services, which is another competitive advantage.
However, other healthcare providers may also have access to advanced technologies
and equipment, so the Lung Center of the Philippines may need to invest in new
technologies to maintain its competitive edge. Although we have just started
implementing an electronic medical records system, once it is fully implemented then
this will improve our competitive advantage.
3. Reputation and brand recognition: The Lung Center of the Philippines, being the
only government owned and controlled corporation that specializes in lung and chest
diseases, has built a strong reputation over the years, which has resulted in high brand
recognition and patient loyalty. This is a significant competitive advantage that the
organization can leverage to attract and retain patients.
4. Cost and affordability: The Lung Center of the Philippines is extremely lucky to
be the recipient of government subsidies, such as the Malasakit funds, which make
sure that our services are affordable to our paying clientele and even made available
for free, especially for indigent patients. The only other places where our services
may be available are in private hospitals, whose cost of services may be 2 or 3 times
more expensive. To maintain its competitive position, the organization may need to
develop more strategies to manage costs while still providing high-quality care.
Overall, the Lung Center of the Philippines appears to have a strong competitive
position in the respiratory care industry, with a focus on quality care, advanced
technology and equipment, and a strong reputation and brand recognition. However,
the organization may need to continue to innovate and differentiate itself to maintain
its competitive edge in an increasingly crowded market.
Value Chain Analysis is a tool that helps organizations identify the activities involved
in creating value for their customers and how these activities can be optimized to
improve performance. Here is an example of a value chain analysis for the Lung
Center of the Philippines:
Primary Activities:
Support Activities:
By analyzing the activities involved in creating value for patients, the Lung Center of
the Philippines can identify areas where it can improve its performance and create a
competitive advantage. For example, the organization may want to focus on
enhancing its procurement processes to reduce costs and improve the availability of
medical supplies and equipment. The organization may also want to focus on
developing new technologies and treatments that can improve patient outcomes and
attract more patients to the center.
D. Financial Analysis
3. Profit margin: This metric measures the percentage of revenue that the Lung
Center of the Philippines retains as profit. A higher profit margin indicates that the
organization is efficient in managing its costs and generating profits. Profit margin is
computed as revenue minus expenses divided by revenue. As can be seen in the
computation for net profit margin, from 2018 to 2020, LCP has a negative net profit
margin, however it seems to be improving. In 2021, the center achieved a net profit
margin of 11%. In 2022, net profit margin became negative again, albeit not as bad as
the previous years. Based solely on revenue from business income and grants, it
would appear that the center is not generating enough profit, or not managing its costs
adequately. Huge influx of subsidy is keeping us afloat, with even a net surplus for
the year. Recalculating net profit margin to include subsidy in the revenue now gives
us a positive profit margin.
4. Return on investment (ROI): This metric measures the profitability of the Lung
Center of the Philippines' investments. A higher ROI indicates that the organization is
generating a good return on its investment. ROI is computed by dividing net income
(plus subsidy) by total operating expenses. Computation of our ROI from 2018-2022
are as follows:
2018 = 1.17%
2019 = 2.99%
2020 = 22.03%
2021 = 53.43%
2022 = 34.66%
The LCP’s ROI has been steadily improving over the past years showing that our
investments on new equipment or services is flowing back in as revenue.
5. Debt-to-equity ratio: This metric measures the amount of debt that the Lung
Center of the Philippines has relative to its equity. A lower debt-to-equity ratio
indicates that the organization is less reliant on debt financing and is therefore less
risky. To compute for our debt-to-equity ratio, we divide the total liabilities by total
net equity. Based on table of financial position, our debt-to-equity ratio from 2018-
2022 are as follows:
2018 = 0.144
2019 = 0.21
2020 = 0.27
2021 = 0.27
2022 = 0.34
6. Cash flow: This metric measures the cash that flows in and out of the Lung Center
of the Philippines' operations. Positive cash flow is important for the organization's
financial stability and ability to invest in new technologies and services. Looking at
the table on cash flows, it is evident that cash inflows from operating activities has
been steadily increasing over the past 4 years. It is also notable that we have been
investing heavily but except for the year 2019, our revenue from operations have been
able to support the cost of operations as well as our investments. We can still improve
our financial performance by reducing costs, increasing revenue and optimizing
investment portfolio.
STRENGTHS
WEAKNESSES
Based on the internal factors analysis conducted using the IFE matrix, the Lung
Center of the Philippines has several strategic issues that need to be addressed to
improve its overall performance and competitiveness. Some of the key strategic
issues that need to be addressed based on the organization's internal factors are:
1. Limited revenue from business income. The Lung Center of the Philippines
relies heavily on government subsidy without which we would have been operating at
a loss. We have to improve on increasing revenue if we want to be financially
sustainable.
2. Limited capacity for inpatient services: The Lung Center of the Philippines has
limited inpatient capacity, which can restrict its ability to provide comprehensive care
to patients. To address this issue, the organization needs to invest in expanding its
inpatient facilities to accommodate more patients and improve its overall service
delivery.
4. Limited resources for research and development: The Lung Center of the
Philippines has limited resources for research and development, which can impact its
ability to innovate and stay competitive in the market. To address this issue, the
organization needs to invest in research and development to ensure that it is staying
up-to-date with the latest medical technologies and advancements.
6. Limited outreach programs: The Lung Center of the Philippines has limited
outreach programs, which can impact its ability to reach a wider patient population.
To address this issue, the organization needs to invest in expanding its outreach
programs to increase its reach and ensure that it is providing respiratory care services
to a larger number of patients.
By addressing these strategic issues, the Lung Center of the Philippines can improve
its overall performance and competitiveness, and better meet the needs of its patients
and stakeholders.
A. SWOT Matrix
Strengths Weaknesses
S1. highly skilled workforce W1. slow ICT project
S2.state of the art implementation
facilities/equipment W2. underutilization of
S3. Clear mission, vision and services
core values W3. dependence on
S4. excellent clinical core government subsidy
services for wide range of W4. lack of effective
respiratory conditions communication of strategy
S5. ISO accredited, PGS W5. limited resources for
silver trailblazer research and development
SO WO
Opportunities 1.Develop and implement 1.Market existing programs
O1. increasing training workshops for allied and advanced services to
demand for health practitioners to enable increase utilization rate and
respiratory health regional lung centers revenue
services from non 2. Conduct in-house skills 2.Secure funding to fast
communicable training workshop for use of track ICT development and
diseases special medical equipment for implementation
O2. increase respiratory health care 3.Develop communication
collaborations and 3. Develop partnerships with channels for exchange of
partnerships international organizations for skills and knowledge
(linkages, medical enhance in skills and among partner hospitals
tourism, knowledge of lung care 4.Secure funding for
international specialists institutional researches
partnerships) 4. Develop marketing
O3. Substantial strategies to advertise our
government skilled workforce and clinical
payment scheme for services
indigent patients 5.
O4. Advances in
ICT
B. SPACE Matrix
Based on the result of the SPACE Matrix graph, it places LCP in the Competitive
Strategy, which means the industry is attractive but relatively unstable due to some
environmental factors such as government regulations which has a great impact on
funding hospital budget since LCP depends on the government subsidy such as HFEP,
DBM, etc.
LCP should focus on a strategy that will focus more on increasing its own hospital
revenue/income and not just depending on government subsidy.
C. Internal-External Matrix
The Internal-External (IE) Matrix is a vital and calculated administration tool that is
used to examine vital position and working of an organization. This matrix also
depends on an examination of the External Factors Evaluation (EFE) and Internal
Factors Evaluation (IFE) that are consolidated into a one model.
As you can see in the graph, the vertical line refers to the average weighted score of
the LCP in the EFE Matrix is 2.28 which means we have an average response to our
key external factors. While the horizontal line refers to the average weighted score of
the LCP in the IFE Matrix is 2.71 which means we also have an average response to
our key internal factors.
The region where the LCP falls can be described as "hold and maintain" which means
we should expand, but not aggressively. Expand means we should penetrate our
market/clients further and develop new services or modify the current service we have.
However, we should probably proceed cautiously and be guided by our financial
position and cash inflows.
Analysis:
The Grand Strategy Matrix is a tool that identifies several strategic options for
companies depending on the strength of their competitive positions and the growth of
their industries.
Based on the Grand Matrix shown above, the LCP falls to the “Quadrant I” which
means we have a Strong Competitive Position with a Rapid Market Growth. We have
identified some key factors/ implications why LCP falls to this quadrant:
E. Summary of Strategies
Strategy 1: Use data analytics for a deeper understanding of revenue cycle to find
opportunities and areas of improvement in hospital profitability
Strategy 5. Increase the number of hospital beds through building new infrastructure.
Strategy 7. Partner with nursing schools to provide clinical work exposure while
augmenting our nursing workforce
Strategy 8. Form alliances with local and international hospitals and organizations for
a sustainable lung transplant program
MISSION: We provide high quality health services and state-of-the-art facilities for
the diagnosis and management of respiratory and chest diseases, and promotion of
lung health for the Filipino people with excellence and compassion, regardless of
creed, color, sex, socio-economic status, and political affiliation.
1. Strategic
a. Short Term
b. Long Term
Community Health Programs: LCP will develop and support community health
programs aimed at promoting preventive healthcare, disease awareness, and health
education. This can include organizing medical missions, health screenings,
vaccination drives, and awareness campaigns on topics like lung health, respiratory
diseases, and healthy lifestyles. Community Outreach Programs were held every
World Asthma Day and World Tuberculosis (TB) Day (March), World No Tobacco
Day (May), World COPD Day (November).
Employee Well-being and Development: LCP can prioritize the well-being and
professional development of its employees. This can include providing a safe and
inclusive work environment, promoting work-life balance, offering training and
development programs, and supporting employee health and wellness initiatives.
Ethical Practices and Governance: LCP can ensure ethical practices and strong
governance throughout its operations. This includes maintaining transparency,
integrity, and accountability in financial reporting, adhering to regulatory standards,
and promoting ethical conduct among employees.
2. Financial Objectives
a. Short term
Increase Revenue from non-health care related activities. Explore areas in the
premises which can be rented out to concessionaires.
b. Long Term
Sustainable Financial Growth: Since this is our weakness, we want to strive for
sustainable financial growth to ensure the long-term viability of LCP. This includes
developing sound financial management practices, exploring diversified revenue
streams, and optimizing resource allocation to support the organization's strategic
objectives.
3: Develop and implement marketing strategy for LCP. This has been a common
clamor among the clinical departments and the most under-used or un-used strategy
7. Partner with nursing schools to provide clinical work exposure while augmenting
our nursing workforce. Diminishing workforce due to migration has affected mainly
our nursing staff. Partnering with nursing schools provides a steady supply of trainees
who may eventually stay on as nursing staff.
8. Form alliances with local and international hospitals and organizations for a
sustainable lung transplant program. One of our flagship programs is lung transplant
program, and if successful, LCP will be the first in the country and would definitely
put as at par with our south east Asian counterparts. Having such a program in our
country would give hope to patients who would otherwise die if not for this
intervention. Organ transplantation is already being performed in the country for
kidney, liver, heart. It is only a matter of time before we can do the same for the lungs.
Corporate Social Responsibility (SCR) is the idea that a company should play a
positive role in the community and consider the environmental and social impact of
business decisions. It is closely linked to sustainability - creating economic, social and
environmental value and ESG, which stands for Environmental, Social, and
Governance. All three focus on non-financial factors that companies, large and small,
should consider when making business decisions. LCP being in the healthcare
business, having a strong corporate social responsibility. All of our decisions making
is aligned with our core functions: providing quality respiratory health care, providing
education and training to produce respiratory health experts, embarking on researches
that will ultimately improve respiratory health outcomes, developing a strong
advocacy arm to promote healthy lungs through patient education and healthy
E. Financial Projections
LCP can develop financial projections by analyzing historical financial data, and
considering factors such as patient volume, healthcare service pricing, and operational
costs. Financial goals can include revenue growth targets, cost reduction initiatives,
and improving financial sustainability. Regular monitoring of actual financial
performance against projections will help LCP make informed decisions and take
corrective actions if necessary. We created two scenarios, one with our regular
targets of 10% annual increase in revenue while maintaining expenses to 5 % or less
and a best case scenario, where we aim for 20% annual increase in revenue and a 10%
increase in operating or investment expenses.
Scenario 1:
Note: 2021 is the baseline for the financial projections for 2022 to 2028. As of this
moment the 2022 Statement of cash flows is not yet finalized for the Lung Center of
the Philippines. Financial projections for revenue and cash inflows are based on a
10% annual increase, while expenses and cash outflows are projected to increase by
5% annually.
Scenario 2:
Note: 2021 is the baseline for the financial projections for 2022 to 2028. As of this
moment the 2022 Statement of cashflows is not yet finalized for the Lung Center of
the Philippines
Financial projections for revenue and cash inflows are based on a 20% annual
increase, while expenses and cash outflows are projected to increase by 10% annually.
2. Marketing Committee This is still sorely lacking in our Center and will have to
be created, but there are several activities that we can already start implementing:
conduct market research to understand patient needs, preferences, and healthcare
trends; develop a marketing strategy to raise awareness about LCP's services, target
the right patient segments, and differentiate from competitors; and implement
marketing tactics such as digital marketing, community outreach, and collaborations
with referring physicians and healthcare institutions.
By aligning these functional strategies with LCP's specific goals and objectives, the
organization can enhance its financial performance, improve operational effectiveness,
attract and retain top talent, reach target patients effectively, and leverage technology
for better patient care and outcomes.
2. Business Continuity Plan: Develop a robust business continuity plan that outlines
strategies and procedures to ensure the continuity of critical operations during a crisis
or disruptive event. This plan should include clear protocols for emergency response,
communication channels, backup systems, and alternative arrangements for essential
services.
6.Training and Drills: Regular training sessions and emergency drills are conducted
to familiarize staff with contingency procedures and ensure they are well-prepared to
respond in real-life situations. This can include training on emergency protocols,
evacuation procedures, first aid, and crisis communication.
8. Regular Review and Updates: Contingency plans should be reviewed, tested, and
updated periodically to ensure they remain effective and relevant. Lessons learned
from past incidents or drills should be incorporated into future planning efforts.
11. An Act Institutionalizing a National Integrated Cancer Control Program and Appropriating
Funds Therefor RA 11215. https://lawphil.net/statutes/repacts/ra2019/ra_11215_2019.html
12. An Act Creating the Philippine Center for Disease Control and Prevention, Defining its
Powers and Functions and for Other Purposes.
https://legacy.senate.gov.ph/lisdata/3258829454!.pdf
13. Annual Audit Report on the Lung Center of the Philippines. 2018-2021